AbbVie Inc. (ABBV) stock prices updated...
Please, Signup (Login) to subscribe or trade (demo)
AbbVie Inc. stock price
AbbVie Inc. latest news:
BRIEF-AbbVie, on conf call, says we need to see HCV market sort itself out
* AbbVie CEO, on conf call, says we need to see HCV market
sort itself out
Why AbbVie Won Big in Q3, and Can Keep Winning
AbbVie increases cash dividend by 11% ahead of earnings
Ahead of its third-quarter earnings release on Friday, AbbVie Inc. said the board will increase the company's cash dividend by 11% to 71 cents a share from 64 cents. The dividend will be paid out Feb. 15, 2018 to shareholders of record as of Jan. 12, 2018. Since its inception in 2013, AbbVie has increased its dividend by more than 77%. Shares of AbbVie are up 43% in the year to date, while the S&P 500 index is up more than 14% and the Dow Jones Industrial Average is up more than 18%.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Where to Find Value in Healthcare Stocks
0 45 Emerging Biotech Market Is It Time To Invest 6 10 Is Large Cap Biotech a Value Trap 160 Gilead Biogen and Bluebird 12 00 Generic Drug Companies Teva Valeant and AbbVie 15 50 Managed Healthcare Sector The Effects Of
DexCom and Rite Aid tumble while Abbott and AbbVie rise
DexCom and Rite Aid fall while Abbott Laboratories and AbbVie jump
AbbVie and Amgen Reach Global Resolution of Humira
BRIEF-AbbVie announces positive topline results from phase 3 trial evaluating Venclexta/Venclyxto tablets in combination with Rituxan
* AbbVie announces positive topline results from phase 3
trial evaluating Venclexta™/Venclyxto™ (Venetoclax) tablets in
combination with Rituxan® (Rituximab) for the treatment of
patients with relapsed/refractory chronic lymphocytic Leukemia
AbbVie says deaths in arthritis trial not linked to drug
AbbVie Inc(ABBV) said on Monday two patients died in a late-stage trial of its rheumatoid arthritis drug but that the deaths were not linked to the drug, which met the study's main goals.
UPDATE 2-AbbVie says deaths in arthritis trial not linked to drug
Sept 11 (Reuters) - AbbVie Inc said on Monday two
patients died in a late-stage trial of its rheumatoid arthritis
drug but that the deaths were not linked to the drug, which met
the study's main goals.
BRIEF-Inventiva and AbbVie extend agreement
INVENTIVA SA: * INVENTIVA AND ABBVIE EXTEND AGREEMENT TO DISCOVER NEW POTENT ORALLY-AVAILABLE SMALL MOLECULE RORΓ INVERSE AGONIST DRUG CANDIDATES.
Abercrombie & Fitch CompanyANF
Aberdeen Greater China FundGCH
Aberdeen Japan Equity FundJEQ
Aberdeen Singapore FundSGF
ABM Industries IncorporatedABM
Acadia Realty TrustAKR
Acco Brands CorporationACCO
Accuride Corporation NewACW